NCT02915432 2021-12-13The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCShanghai Junshi Bioscience Co., Ltd.Phase 1/2 Unknown401 enrolled 1 FDA
NCT00874614 2020-02-20A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/ParagangliomaMolecular Insight Pharmaceuticals, Inc.Phase 2 Unknown74 enrolled 10 charts 1 FDA